[Molecular genetics and phenotypic features of congenital isolated hypogonadotropic hypogonadism]

Area of Science:

• Endocrinology
• Genetics
• Reproductive Medicine

Background:

• Congenital isolated hypogonadotropic hypogonadism (IHH) results from impaired gonadotropin-releasing hormone (GNRH) or gonadotropin function.
• Kallmann syndrome, a subtype of IHH, is characterized by hypogonadism and impaired sense of smell, affecting approximately 50% of patients.
• Over 40 genes are implicated in the hypothalamic-pituitary-gonadal axis, with diverse molecular defects contributing to IHH phenotypes.

Purpose of the Study:

• To review current understanding of genetic factors in congenital hypogonadotropic hypogonadism.
• To explore the relationship between molecular defects, clinical presentation, and therapeutic outcomes.
• To discuss the implications of oligogenicity and propose revisions to IHH classification.

Main Methods:

• Literature review of genetic associations and clinical data in IHH.
• Analysis of genotype-phenotype correlations in congenital malformations.
• Examination of studies on oligogenic contributions to IHH.

Main Results:

• Genetic mutations in over 40 genes are linked to IHH, affecting GNRH secretion and action.
• Phenotypic variability exists even within families sharing the same genetic defect.
• Oligogenicity plays a significant role in shaping the IHH phenotype.

Conclusions:

• Genotype-phenotype correlation is crucial for identifying causative mutations in IHH.
• Current definitions and classifications of IHH may require revision due to emerging genetic findings.
• Understanding genetic heterogeneity is key to personalized diagnosis and treatment of IHH.